Daniel P Cook

9PUBLICATIONS
24CO-AUTHORS
Cancer geneticsChemical engineering designEpidemiological modellingInnate immunityLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 29, 2026
Considerations for early life genetic therapies in cystic fibrosis.

|Jan 03, 2026
Genetic diversity of Collaborative Cross mice implicates FFAR3 as a target for ILC2 anti-inflammatory reprogramming.

Mark Rusznak, Shinji Toki, Yajing Hao

|Oct 06, 2025
In mechanically ventilated, critically ill adults, conservative vs. usual supplemental oxygen did not reduce mortality at 90 d.

Daniel P Cook

|May 07, 2025
PGI2 restricts trained ILC2 responses in allergic inflammation.

Weisong Zhou, Jian Zhang, Allison E Norlander

|Mar 23, 2023
Cystic Fibrosis Reprograms Airway Epithelial IL-33 Release and Licenses IL-33-Dependent Inflammation.

Daniel P Cook, Christopher M Thomas, Ashley Y Wu

|Jun 25, 2021
Early Lung Disease Exhibits Bacteria-Dependent and -Independent Abnormalities in Cystic Fibrosis Pigs.

Drake C Bouzek, Mahmoud H Abou Alaiwa, Ryan J Adam

Pageof 2

Frequent Collaborators

3 joint publications

David A Stoltz

2 joint publications

R Stokes Peebles

1 joint publications

Leah R Reznikov

1 joint publications

Vern Eric Kerchberger